UBS lowered the firm’s price target on Dentsply Sirona (XRAY) to $25 from $27 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona’s Q1 2025 Financial Performance Overview
- DENTSPLY SIRONA: Strong Earnings Overshadowed by Leadership Changes and Market Uncertainties
- DENTSPLY SIRONA: Hold Rating Amid Stabilizing Growth and Macro Challenges
- Dentsply Sirona’s Earnings Call: Growth Amid Challenges
- Cautious Optimism for DENTSPLY SIRONA Amid Recovery and Challenges: Hold Rating Maintained with Price Target at $17